No Data
No Data
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Scinai Immunotherapeutics Eyes Debt-Equity Swap
Scinai Immunotherapeutics Strives for Nasdaq Compliance
Express News | Scinai Immunotherapeutics Receives Receipt Of Updated LoI From European Investment Bank Providing Specific Terms For Conversion Of It Loan To Equity
Scinai Immunotherapeutics Announces Receipt of an Updated Letter of Intent From the European Investment Bank Providing Specific Terms for Conversion of Its Loan to Equity
JERUSALEM, July 8, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) (the "Company"), a biotechnology company focused on developing inflammation and immunology (I&I) biological produc
Express News | Scinai Immunotherapeutics Receives Nasdaq Approval To Continue Listing; Must Meet Equity Requirement By August 14, 2024
No Data
WarrenC : great eye my dude
TrytosaveabitOP WarrenC: Thank you! Have a great weekend